Dr. Stephen A. Renae, MD

Dr. Renae practices at Can Community Health, Inc. in Sarasota, Florida.

Dr. Renae's NPI, 1841296670, was assigned on June 27, 2005. Dr. Renae graduated from St. George's University School of Medicine in 1987. Dr. Renae holds Florida license ME0063353.

Dr. Renae's primary practice is Can Community Health, Inc., at 1231 N Tuttle Ave, Sarasota, FL 34237 in Sarasota County. The practice phone is (941) 366-0134.

Dr. Renae's primary practice is Can Community Health, Inc. in Sarasota, Florida. Dr. Renae is also affiliated with Holy Cross Health. The medical group on file is CAN Community Health. Dmand AI also links Dr. Renae to 1 more hospital, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Renae practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Renae's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Renae is board certified in infectious disease by the American Board of Internal Medicine. Dr. Renae is licensed in Florida.

Dmand AI lists acute sinusitis, acute skin infection, bronchitis, cold sores or genital herpes, endocarditis, hiv/aids, immune deficiency disease and joint or bone infection among the conditions Dr. Renae treats.

CMS data shows 4,519 Medicare services from Dr. Renae across 12 procedure codes in 2024, for 587 Medicare patients. Medicare paid $380,175 for them.

CMS counts 587 Medicare patients who saw Dr. Renae in 2024. The largest group is 65 to 74, with 222 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Renae's median patient age at 64, with 32% women.

In 2024, Dr. Renae wrote 6,131 Medicare Part D claims for 560 patients. 40% of them were for generic drugs. CMS names the drug for 5,562 of them, across 90 drugs with 11 or more claims each, at $11,184,359 in total drug cost. In 2023, CMS named 4,059 claims across 77 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Renae for performance year 2024, reported individually. Dr. Renae accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Renae as offering telehealth.

CMS Open Payments shows 741 general payments to Dr. Renae from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Gilead Sciences, Inc. paid the most, $6,582.

Dmand AI lists 3 awards for Dr. Renae, most recently CMS Stage 1 EHR in 2013.

Dr. Renae graduated from St. George's University School of Medicine in 1987. Dr. Renae is a member of ACP and FMA.

Dr. Renae is in network with 15 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.